EIHA hits at pharma firms in CBD skirmish

The European Industrial Hemp Association (EIHA) this week criticized “a few pharmaceutical companies” for leading a fight for legislation that would make CBD a prescription-only drug, on the heels of recent developments in Germany and the UK. The Association called for “urgent” action to overcome what it sees at present as “only a tenuous patchwork of CBD-regulation(s)” currently on the books.

More: http://hemptoday.net/eiha-lashes-out-at-pharma-firms/

Related Posts